chr1-204132194-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_018208.4(ETNK2):c.1151T>A(p.Met384Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000141 in 1,420,074 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
ETNK2
NM_018208.4 missense
NM_018208.4 missense
Scores
11
8
Clinical Significance
Conservation
PhyloP100: 3.94
Genes affected
ETNK2 (HGNC:25575): (ethanolamine kinase 2) The protein encoded by this gene is a member of choline/ethanolamine kinase family which catalyzes the first step of phosphatidylethanolamine (PtdEtn) biosynthesis via the cytidine diphosphate (CDP) ethanolamine pathway. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETNK2 | NM_018208.4 | c.1151T>A | p.Met384Lys | missense_variant | 8/8 | ENST00000367202.9 | NP_060678.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ETNK2 | ENST00000367202.9 | c.1151T>A | p.Met384Lys | missense_variant | 8/8 | 1 | NM_018208.4 | ENSP00000356170 | P1 | |
ETNK2 | ENST00000422072.5 | c.440T>A | p.Met147Lys | missense_variant | 5/5 | 3 | ENSP00000410580 | |||
ETNK2 | ENST00000367197.5 | c.197T>A | p.Met66Lys | missense_variant | 5/5 | 3 | ENSP00000356165 | |||
ETNK2 | ENST00000367201.7 | c.*72T>A | 3_prime_UTR_variant | 8/8 | 2 | ENSP00000356169 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000141 AC: 2AN: 1420074Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 702124
GnomAD4 exome
AF:
AC:
2
AN:
1420074
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
702124
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.1151T>A (p.M384K) alteration is located in exon 8 (coding exon 8) of the ETNK2 gene. This alteration results from a T to A substitution at nucleotide position 1151, causing the methionine (M) at amino acid position 384 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;.
Vest4
MutPred
Loss of ubiquitination at K386 (P = 0.0141);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at